Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 8 | 2023 | 955 | 1.920 |
Why?
|
| Genome-Wide Association Study | 7 | 2023 | 1621 | 0.920 |
Why?
|
| Sex Characteristics | 3 | 2021 | 319 | 0.870 |
Why?
|
| DNA Methylation | 6 | 2023 | 628 | 0.860 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2021 | 2357 | 0.820 |
Why?
|
| Hypersensitivity | 1 | 2023 | 154 | 0.800 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 30 | 0.780 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 48 | 0.780 |
Why?
|
| Genes, X-Linked | 1 | 2021 | 37 | 0.770 |
Why?
|
| Leukocytes | 1 | 2021 | 202 | 0.720 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 132 | 0.710 |
Why?
|
| Linkage Disequilibrium | 5 | 2010 | 473 | 0.680 |
Why?
|
| Puberty | 1 | 2018 | 59 | 0.640 |
Why?
|
| Multigene Family | 2 | 2010 | 202 | 0.600 |
Why?
|
| Estrogens | 1 | 2018 | 200 | 0.600 |
Why?
|
| Cytokines | 1 | 2020 | 776 | 0.570 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1135 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 2271 | 0.530 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 296 | 0.530 |
Why?
|
| Gene Frequency | 5 | 2011 | 677 | 0.520 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2006 | 79 | 0.520 |
Why?
|
| Chimerism | 1 | 2013 | 37 | 0.450 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 62 | 0.430 |
Why?
|
| Genotype | 8 | 2023 | 1851 | 0.400 |
Why?
|
| Primates | 1 | 2012 | 151 | 0.390 |
Why?
|
| Child | 7 | 2023 | 6928 | 0.380 |
Why?
|
| Olfactory Perception | 1 | 2010 | 21 | 0.360 |
Why?
|
| Quantitative Trait Loci | 4 | 2021 | 576 | 0.360 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 37 | 0.350 |
Why?
|
| Hominidae | 1 | 2010 | 96 | 0.350 |
Why?
|
| Interleukin-4 | 1 | 2009 | 127 | 0.350 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 819 | 0.340 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 479 | 0.340 |
Why?
|
| Genetic Variation | 3 | 2005 | 1351 | 0.330 |
Why?
|
| HLA Antigens | 1 | 2010 | 232 | 0.320 |
Why?
|
| Haplotypes | 4 | 2012 | 642 | 0.320 |
Why?
|
| Integrin beta3 | 1 | 2007 | 30 | 0.300 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 41 | 0.300 |
Why?
|
| Immunophenotyping | 1 | 2007 | 211 | 0.290 |
Why?
|
| Genetics, Population | 1 | 2010 | 394 | 0.290 |
Why?
|
| Adolescent | 7 | 2023 | 8982 | 0.290 |
Why?
|
| Receptors, Steroid | 1 | 2005 | 42 | 0.260 |
Why?
|
| Models, Genetic | 2 | 2012 | 926 | 0.260 |
Why?
|
| Water-Electrolyte Balance | 1 | 2004 | 66 | 0.250 |
Why?
|
| Young Adult | 6 | 2021 | 5976 | 0.250 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 813 | 0.240 |
Why?
|
| Species Specificity | 3 | 2012 | 678 | 0.240 |
Why?
|
| Environment | 1 | 2005 | 219 | 0.240 |
Why?
|
| Humans | 21 | 2023 | 86645 | 0.230 |
Why?
|
| Lung | 3 | 2023 | 1170 | 0.230 |
Why?
|
| CpG Islands | 1 | 2023 | 151 | 0.220 |
Why?
|
| Aging | 1 | 2007 | 691 | 0.220 |
Why?
|
| Phenotype | 3 | 2020 | 2378 | 0.210 |
Why?
|
| DNA | 2 | 2023 | 1294 | 0.210 |
Why?
|
| Male | 10 | 2021 | 40967 | 0.210 |
Why?
|
| Female | 11 | 2021 | 44534 | 0.200 |
Why?
|
| Adult | 8 | 2023 | 25648 | 0.190 |
Why?
|
| Genomics | 2 | 2023 | 720 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1920 | 0.190 |
Why?
|
| Base Sequence | 4 | 2011 | 2330 | 0.190 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2020 | 77 | 0.180 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6509 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 193 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 286 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 3030 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2010 | 125 | 0.170 |
Why?
|
| Endocrine System | 1 | 2018 | 17 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 110 | 0.150 |
Why?
|
| Middle Aged | 6 | 2021 | 25028 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2021 | 409 | 0.150 |
Why?
|
| Immunity | 1 | 2018 | 136 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 196 | 0.150 |
Why?
|
| Aged | 4 | 2021 | 18415 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 689 | 0.140 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2006 | 43 | 0.130 |
Why?
|
| Phylogeny | 3 | 2012 | 1137 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1384 | 0.130 |
Why?
|
| Alleles | 2 | 2012 | 1128 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 853 | 0.120 |
Why?
|
| Risk Factors | 2 | 2020 | 5417 | 0.120 |
Why?
|
| DNA Primers | 2 | 2005 | 543 | 0.120 |
Why?
|
| Biomarkers | 1 | 2020 | 1718 | 0.120 |
Why?
|
| Infant | 2 | 2013 | 3047 | 0.120 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.120 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 37 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2013 | 2767 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2013 | 34 | 0.120 |
Why?
|
| Child, Preschool | 2 | 2013 | 3613 | 0.110 |
Why?
|
| South Dakota | 2 | 2010 | 47 | 0.110 |
Why?
|
| Cercopithecidae | 1 | 2012 | 13 | 0.110 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 26 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 183 | 0.100 |
Why?
|
| Respiration | 1 | 2013 | 262 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 81 | 0.100 |
Why?
|
| Microvessels | 1 | 2011 | 70 | 0.100 |
Why?
|
| Exons | 1 | 2012 | 450 | 0.100 |
Why?
|
| Blood Group Antigens | 1 | 2010 | 17 | 0.100 |
Why?
|
| Endangered Species | 1 | 2010 | 23 | 0.100 |
Why?
|
| Animals, Wild | 1 | 2010 | 40 | 0.090 |
Why?
|
| Animals | 5 | 2012 | 26582 | 0.090 |
Why?
|
| Pheromones, Human | 1 | 2010 | 7 | 0.090 |
Why?
|
| Animals, Zoo | 1 | 2010 | 64 | 0.090 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 1074 | 0.090 |
Why?
|
| Founder Effect | 1 | 2010 | 104 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 246 | 0.090 |
Why?
|
| Logistic Models | 1 | 2013 | 1187 | 0.090 |
Why?
|
| Lipoprotein(a) | 1 | 2009 | 28 | 0.090 |
Why?
|
| Pregnancy | 2 | 2013 | 2894 | 0.080 |
Why?
|
| Introns | 1 | 2009 | 289 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 329 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 294 | 0.080 |
Why?
|
| Genetic Linkage | 1 | 2010 | 623 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 270 | 0.080 |
Why?
|
| Respiratory Sounds | 1 | 2007 | 33 | 0.080 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2007 | 62 | 0.070 |
Why?
|
| Mutation | 2 | 2012 | 3968 | 0.070 |
Why?
|
| Geography | 2 | 2004 | 223 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 927 | 0.070 |
Why?
|
| Los Angeles | 1 | 2004 | 28 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2005 | 251 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2004 | 88 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2705 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 210 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 122 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1075 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 1054 | 0.050 |
Why?
|
| Duffy Blood-Group System | 1 | 2001 | 7 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2021 | 24 | 0.050 |
Why?
|
| Rhinovirus | 1 | 2021 | 25 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 1098 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1830 | 0.050 |
Why?
|
| Genome, Human | 1 | 2005 | 756 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2021 | 361 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 2262 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 609 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2001 | 502 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 669 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 1284 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 1565 | 0.040 |
Why?
|
| Chromatin | 1 | 2018 | 380 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 136 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 69 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 22 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2012 | 40 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2012 | 33 | 0.030 |
Why?
|
| Linear Models | 1 | 2011 | 421 | 0.020 |
Why?
|
| Kringles | 1 | 2009 | 6 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 879 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 912 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 353 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
| Religion | 1 | 2009 | 87 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 266 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2468 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1197 | 0.020 |
Why?
|
| Cameroon | 1 | 2001 | 14 | 0.010 |
Why?
|
| Pakistan | 1 | 2001 | 15 | 0.010 |
Why?
|
| Italy | 1 | 2001 | 106 | 0.010 |
Why?
|
| Population Density | 1 | 2001 | 60 | 0.010 |
Why?
|
| China | 1 | 2001 | 228 | 0.010 |
Why?
|
| United States | 1 | 2013 | 6674 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 439 | 0.010 |
Why?
|